3 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Ampersand Competitors or Alternatives

Ampersand's top competitors include Asimov, Laronde and Strand.

Unlock 8 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Ampersand's company profile

Jason Gardner

CEO

90/100
1 - 25
$115M
$100K - 5M
  • $115M
    $100K - 5M
  • 1 - 25
    $115M
  • $100K - 5M
  • 90/100
  • 1 - 25
  • $115M
  • $100K - 5M
View ProfileView
1
Ampersand's Competitor - Asimov logo

Alec Nielsen

Co-Founder & CEO

- -
25 - 100
$204.7M
$100K - 5M
  • $204.7M
    $100K - 5M
  • 25 - 100
    $204.7M
  • $100K - 5M
  • - -
  • 25 - 100
  • $204.7M
  • $100K - 5M
View ProfileView
2
Ampersand's Competitor - Laronde logo

John Mendlein

Interim-CEO

90/100
25 - 100
$490M
$5M - 25M
  • $490M
    $5M - 25M
  • 25 - 100
    $490M
  • $5M - 25M
  • 90/100
  • 25 - 100
  • $490M
  • $5M - 25M
View ProfileView
3
Ampersand's Competitor - Strand logo

Jake Becraft

Co-Founder & CEO

90/100
25 - 100
$103.3M
$100K - 5M
  • $103.3M
    $100K - 5M
  • 25 - 100
    $103.3M
  • $100K - 5M
  • 90/100
  • 25 - 100
  • $103.3M
  • $100K - 5M
View ProfileView
4
Ampersand's Competitor - Amunix logo

Angie You

CEO

82/100
25 - 100
$230M
$5M - 25M
  • $230M
    $5M - 25M
  • 25 - 100
    $230M
  • $5M - 25M
  • 82/100
  • 25 - 100
  • $230M
  • $5M - 25M
View ProfileView
5
Ampersand's Competitor - Arrowhead logo

Christopher Anzalone

President & CEO

78/100
400
$1.2B
$2.5M
  • $1.2B
    $2.5M
  • 400
    $1.2B
  • $2.5M
  • 78/100
  • 400
  • $1.2B
  • $2.5M
View ProfileView
Ampersand's top 11 competitors are Asimov, Laronde, Strand, Alnylam, Amunix, Arrowhead, Ra Pharma, Voyager, Regulus, Genentech and Intas. Together they have raised over 9.9B between their estimated 24.3K employees. Ampersand's revenue is the ranked 12th among it's top 10 competitors. The top 10 competitors average 2.6B. Ampersand has 20 employees and is ranked 12th among it's top 10 competitors. The top 10 competitors average 2,028.

Ampersand VS Asimov

Asimov is Ampersand's #1 rival. Asimov is a Private company that was founded in Boston, Massachusetts in 2017. Like Ampersand, Asimov also works within the Pharmaceuticals & Biotechnology field. Asimov has 25 more employees vs. Ampersand.

Ampersand VS Laronde

Laronde is perceived as one of Ampersand's biggest rivals. Laronde was founded in 2017, and is headquartered in Cambridge, Massachusetts. Like Ampersand, Laronde also operates in the Biotechnology sector. Laronde generates $4M more revenue vs. Ampersand.

Ampersand VS Strand

Strand is a top competitor of Ampersand. Strand is a Private company that was founded in 2017 in Boston, Massachusetts. Like Ampersand, Strand also operates in the Biotechnology space. Compared to Ampersand, Strand has 5 more employees.

Looking for similar companies to Ampersand?

Similar Companies

Biotechnology companies in Boston

See 270 companies 
Biotechnology companies in Greater Boston

See 1,266 companies 
Pharmaceuticals & Biotechnology companies in Boston

See 340 companies 
Biotechnology companies in Massachusetts

See 1,343 companies 
Companies in Boston with employees in 1-25 range

See 1,389 companies 
Pharmaceuticals & Biotechnology companies in Greater Boston

See 1,622 companies 
Pharmaceuticals & Biotechnology companies in Massachusetts

See 1,717 companies 
Biotechnology companies with employees in 1-25 range

See 3,305 companies 
Companies in Boston with revenue in $100K-5.0M range

See 3,373 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Ampersand and Ampersand's Competitors

March 31, 2025Benzinga
- Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and li...
March 30, 2025Life Care News
− New Data Follow Recent U.S. FDA Approval of AMVUTTRA® (vutrisiran) as First RNAi Therapeutic to Reduce Cardiovascular Death, Cardiovascular Hospitali...
March 31, 2025Pharmabiz
Novartis announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for patients with prostate─...
April 1, 2025Benzinga
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:Do you, or did you, own shares of Merck & Co., Inc. (NYSE:MRK)?Did you purchase you...
April 1, 2025Pharmabiz
AstraZeneca's Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy ...
March 31, 2025Pharmabiz
Bristol Myers Squibb announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended ap...
April 1, 2025PR Newswire
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Intellia Therapeutics, Inc. ("Intellia" or the "Company") (NASDAQ: NTLA) of a class action....
April 1, 2025PR Newswire
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK) of a class action securities lawsu...
March 31, 2025Benzinga
FDA approved AstraZeneca's Imfinzi regimen for muscle-invasive bladder cancer, while the EU backed Calquence combo for untreated mantle cell lymphoma. ...
April 1, 2025Korea Biomedical Review
Novartis has scored a win in Korea's reimbursement system, clearing its immunosuppressant Cosentyx (secukinumab) for use in children and teens with chr...

Frequently Asked Questions about Ampersand

  1. Who are Ampersand's top competitors?

    Ampersand's top 3 competitors are Asimov, Laronde, Strand.

  2. Who is similar to Ampersand?

    Asimov is the most similar to Ampersand. Laronde and Strand are also similar to Ampersand.

  1. Are Ampersand and Asimov competitors?

    Yes, Asimov is one of Ampersand’s top competitors.